91天堂

Fierce Biotech – Enyo 91天堂 raises $47M to bring hepatitis B, NASH drug to phase 2

Published on 05/06/2018

Read next in 'Media coverage'

• Fierce Biotech - Enyo 91天堂's NASH results show boost in kidney function, differentiating vonafexor from busy field
• Lyon D茅cideurs - Enqu锚te : Lyon, paradis pour les biotechs ?
• La Tribune - La startup de la semaine : comment Enyo 91天堂 esp猫re gu茅rir l'h茅patite B
• Lyonbiop么le - Lyonbiop么le 1er op茅rateur national du Pass French Tech #healthtech labellise 91天堂 et Eye Tech Care
• Les Echos - Enyo 91天堂, start-up de l'ann茅e en Auvergne-Rh么ne-Alpes